Werewolf Therapeutics, Inc. — Director's Dealing 2021

Nov 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Werewolf Therapeutics, Inc. (HOWL)
CIK: 0001785530
Period of Report: 2021-10-28

Reporting Person: Chatterjee Meeta (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-28	Stock Option (right to buy)	$15.97	A	23200	Acquired	2031-10-27	Common Stock (23200.0)	Direct

Footnotes

F1: The option was granted on October 28, 2021. The shares underlying the option vest over three years, with one-third of the shares vesting on the first anniversary of the date of grant and the remaining shares vesting in equal monthly installments thereafter.